ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
16.63
0.00 (0.00%)
Sep 3, 2025, 8:00 PM EDT
ResMed Employees
ResMed had 10,600 employees as of June 30, 2025. The number of employees increased by 620 or 6.21% compared to the previous year.
Employees
10,600
Change (1Y)
620
Growth (1Y)
6.21%
Revenue / Employee
$485,503
Profits / Employee
$132,144
Market Cap
40.43B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 10,600 | 620 | 6.21% |
Jun 30, 2024 | 9,980 | -160 | -1.58% |
Jun 30, 2023 | 10,140 | 1,980 | 24.26% |
Jun 30, 2022 | 8,160 | 190 | 2.38% |
Jun 30, 2021 | 7,970 | 200 | 2.57% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Elite Pharmaceuticals | 68 |
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
HealthLynked | 20 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
ResMed News
- 3 days ago - ResMed Inc (RMD) Launches Global Initiative to Revolutionize Sleep Health Care | RMD stock news - GuruFocus
- 3 days ago - Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority - GlobeNewsWire
- 10 days ago - Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds - GlobeNewsWire
- 10 days ago - ResMed: A Dividend Opportunity In The MedTech Space As The Company Grows - Seeking Alpha
- 19 days ago - Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio - GlobeNewsWire
- 4 weeks ago - How Resmed’s Mick Farrell turned a $7b company into a $62b giant - The Australian Financial Review
- 4 weeks ago - Top 50 High-Quality Dividend Stocks For August 2025 - Seeking Alpha
- 4 weeks ago - ResMed RMD Q4 2025 Earnings Call Transcript - The Motley Fool